Global Breast Cancer Liquid Biopsy Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Breast Cancer Liquid Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Breast Cancer Liquid Biopsy market size is estimated to be worth US$ 330.1 million in 2021 and is forecast to a readjusted size of USD 971.4 million by 2028 with a CAGR of 16.7% during review period. Hospitals accounting for % of the Breast Cancer Liquid Biopsy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Circulating Tumor Cells (CTCs) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Breast Cancer Liquid Biopsy include QIAGEN, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, and Menarini Silicon Biosystems, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Breast Cancer Liquid Biopsy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Circulating Tumor Cells (CTCs)
Cell-Free DNA (CfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
Market segment by Application, can be divided into
Hospitals
Diagnostic Centers
Laboratories
Market segment by players, this report covers
QIAGEN
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini Silicon Biosystems
Genomic Health
Thermo Fisher Scientific
Illumina
Biocept
Trovagene
Guardant Health
RainDance Technologies
MDx Health
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Breast Cancer Liquid Biopsy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Breast Cancer Liquid Biopsy, with revenue, gross margin and global market share of Breast Cancer Liquid Biopsy from 2019 to 2022.
Chapter 3, the Breast Cancer Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Breast Cancer Liquid Biopsy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Breast Cancer Liquid Biopsy research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Breast Cancer Liquid Biopsy
1.2 Classification of Breast Cancer Liquid Biopsy by Type
1.2.1 Overview: Global Breast Cancer Liquid Biopsy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Type in 2021
1.2.3 Circulating Tumor Cells (CTCs)
1.2.4 Cell-Free DNA (CfDNA)
1.2.5 Extracellular Vesicles (EVs)
1.2.6 Other Circulating Biomarkers
1.3 Global Breast Cancer Liquid Biopsy Market by Application
1.3.1 Overview: Global Breast Cancer Liquid Biopsy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Laboratories
1.4 Global Breast Cancer Liquid Biopsy Market Size & Forecast
1.5 Global Breast Cancer Liquid Biopsy Market Size and Forecast by Region
1.5.1 Global Breast Cancer Liquid Biopsy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Breast Cancer Liquid Biopsy Market Size by Region, (2017-2022)
1.5.3 North America Breast Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.5.4 Europe Breast Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Breast Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.5.6 South America Breast Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Breast Cancer Liquid Biopsy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Breast Cancer Liquid Biopsy Market Drivers
1.6.2 Breast Cancer Liquid Biopsy Market Restraints
1.6.3 Breast Cancer Liquid Biopsy Trends Analysis
2 Company Profiles
2.1 QIAGEN
2.1.1 QIAGEN Details
2.1.2 QIAGEN Major Business
2.1.3 QIAGEN Breast Cancer Liquid Biopsy Product and Solutions
2.1.4 QIAGEN Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 QIAGEN Recent Developments and Future Plans
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Product and Solutions
2.2.4 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Roche Diagnostics Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Solutions
2.3.4 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Myriad Genetics
2.4.1 Myriad Genetics Details
2.4.2 Myriad Genetics Major Business
2.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Product and Solutions
2.4.4 Myriad Genetics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Myriad Genetics Recent Developments and Future Plans
2.5 Menarini Silicon Biosystems
2.5.1 Menarini Silicon Biosystems Details
2.5.2 Menarini Silicon Biosystems Major Business
2.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Solutions
2.5.4 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Menarini Silicon Biosystems Recent Developments and Future Plans
2.6 Genomic Health
2.6.1 Genomic Health Details
2.6.2 Genomic Health Major Business
2.6.3 Genomic Health Breast Cancer Liquid Biopsy Product and Solutions
2.6.4 Genomic Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Genomic Health Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Solutions
2.7.4 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business
2.8.3 Illumina Breast Cancer Liquid Biopsy Product and Solutions
2.8.4 Illumina Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Illumina Recent Developments and Future Plans
2.9 Biocept
2.9.1 Biocept Details
2.9.2 Biocept Major Business
2.9.3 Biocept Breast Cancer Liquid Biopsy Product and Solutions
2.9.4 Biocept Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Biocept Recent Developments and Future Plans
2.10 Trovagene
2.10.1 Trovagene Details
2.10.2 Trovagene Major Business
2.10.3 Trovagene Breast Cancer Liquid Biopsy Product and Solutions
2.10.4 Trovagene Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Trovagene Recent Developments and Future Plans
2.11 Guardant Health
2.11.1 Guardant Health Details
2.11.2 Guardant Health Major Business
2.11.3 Guardant Health Breast Cancer Liquid Biopsy Product and Solutions
2.11.4 Guardant Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Guardant Health Recent Developments and Future Plans
2.12 RainDance Technologies
2.12.1 RainDance Technologies Details
2.12.2 RainDance Technologies Major Business
2.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Product and Solutions
2.12.4 RainDance Technologies Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 RainDance Technologies Recent Developments and Future Plans
2.13 MDx Health
2.13.1 MDx Health Details
2.13.2 MDx Health Major Business
2.13.3 MDx Health Breast Cancer Liquid Biopsy Product and Solutions
2.13.4 MDx Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 MDx Health Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Breast Cancer Liquid Biopsy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Breast Cancer Liquid Biopsy Players Market Share in 2021
3.2.2 Top 10 Breast Cancer Liquid Biopsy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Breast Cancer Liquid Biopsy Players Head Office, Products and Services Provided
3.4 Breast Cancer Liquid Biopsy Mergers & Acquisitions
3.5 Breast Cancer Liquid Biopsy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Breast Cancer Liquid Biopsy Revenue and Market Share by Type (2017-2022)
4.2 Global Breast Cancer Liquid Biopsy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2017-2022)
5.2 Global Breast Cancer Liquid Biopsy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Breast Cancer Liquid Biopsy Revenue by Type (2017-2028)
6.2 North America Breast Cancer Liquid Biopsy Revenue by Application (2017-2028)
6.3 North America Breast Cancer Liquid Biopsy Market Size by Country
6.3.1 North America Breast Cancer Liquid Biopsy Revenue by Country (2017-2028)
6.3.2 United States Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
6.3.3 Canada Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
6.3.4 Mexico Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Breast Cancer Liquid Biopsy Revenue by Type (2017-2028)
7.2 Europe Breast Cancer Liquid Biopsy Revenue by Application (2017-2028)
7.3 Europe Breast Cancer Liquid Biopsy Market Size by Country
7.3.1 Europe Breast Cancer Liquid Biopsy Revenue by Country (2017-2028)
7.3.2 Germany Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7.3.3 France Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7.3.5 Russia Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
7.3.6 Italy Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Type (2017-2028)
8.2 Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Application (2017-2028)
8.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Region (2017-2028)
8.3.2 China Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.3 Japan Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.4 South Korea Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.5 India Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
8.3.7 Australia Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Breast Cancer Liquid Biopsy Revenue by Type (2017-2028)
9.2 South America Breast Cancer Liquid Biopsy Revenue by Application (2017-2028)
9.3 South America Breast Cancer Liquid Biopsy Market Size by Country
9.3.1 South America Breast Cancer Liquid Biopsy Revenue by Country (2017-2028)
9.3.2 Brazil Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
9.3.3 Argentina Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Type (2017-2028)
10.2 Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Application (2017-2028)
10.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Country (2017-2028)
10.3.2 Turkey Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
10.3.4 UAE Breast Cancer Liquid Biopsy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Breast Cancer Liquid Biopsy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Breast Cancer Liquid Biopsy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Breast Cancer Liquid Biopsy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Breast Cancer Liquid Biopsy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Breast Cancer Liquid Biopsy Revenue Market Share by Region (2023-2028)
Table 6. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 7. QIAGEN Major Business
Table 8. QIAGEN Breast Cancer Liquid Biopsy Product and Solutions
Table 9. QIAGEN Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics Major Business
Table 12. Roche Diagnostics Breast Cancer Liquid Biopsy Product and Solutions
Table 13. Roche Diagnostics Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories Major Business
Table 16. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Solutions
Table 17. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 19. Myriad Genetics Major Business
Table 20. Myriad Genetics Breast Cancer Liquid Biopsy Product and Solutions
Table 21. Myriad Genetics Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Menarini Silicon Biosystems Corporate Information, Head Office, and Major Competitors
Table 23. Menarini Silicon Biosystems Major Business
Table 24. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Solutions
Table 25. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Genomic Health Corporate Information, Head Office, and Major Competitors
Table 27. Genomic Health Major Business
Table 28. Genomic Health Breast Cancer Liquid Biopsy Product and Solutions
Table 29. Genomic Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 31. Thermo Fisher Scientific Major Business
Table 32. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Solutions
Table 33. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Illumina Corporate Information, Head Office, and Major Competitors
Table 35. Illumina Major Business
Table 36. Illumina Breast Cancer Liquid Biopsy Product and Solutions
Table 37. Illumina Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Biocept Corporate Information, Head Office, and Major Competitors
Table 39. Biocept Major Business
Table 40. Biocept Breast Cancer Liquid Biopsy Product and Solutions
Table 41. Biocept Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Trovagene Corporate Information, Head Office, and Major Competitors
Table 43. Trovagene Major Business
Table 44. Trovagene Breast Cancer Liquid Biopsy Product and Solutions
Table 45. Trovagene Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Guardant Health Corporate Information, Head Office, and Major Competitors
Table 47. Guardant Health Major Business
Table 48. Guardant Health Breast Cancer Liquid Biopsy Product and Solutions
Table 49. Guardant Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. RainDance Technologies Corporate Information, Head Office, and Major Competitors
Table 51. RainDance Technologies Major Business
Table 52. RainDance Technologies Breast Cancer Liquid Biopsy Product and Solutions
Table 53. RainDance Technologies Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. MDx Health Corporate Information, Head Office, and Major Competitors
Table 55. MDx Health Major Business
Table 56. MDx Health Breast Cancer Liquid Biopsy Product and Solutions
Table 57. MDx Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Breast Cancer Liquid Biopsy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Breast Cancer Liquid Biopsy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Breast Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Breast Cancer Liquid Biopsy Players Head Office, Products and Services Provided
Table 62. Breast Cancer Liquid Biopsy Mergers & Acquisitions in the Past Five Years
Table 63. Breast Cancer Liquid Biopsy New Entrants and Expansion Plans
Table 64. Global Breast Cancer Liquid Biopsy Revenue (USD Million) by Type (2017-2022)
Table 65. Global Breast Cancer Liquid Biopsy Revenue Share by Type (2017-2022)
Table 66. Global Breast Cancer Liquid Biopsy Revenue Forecast by Type (2023-2028)
Table 67. Global Breast Cancer Liquid Biopsy Revenue by Application (2017-2022)
Table 68. Global Breast Cancer Liquid Biopsy Revenue Forecast by Application (2023-2028)
Table 69. North America Breast Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Breast Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Breast Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Breast Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Breast Cancer Liquid Biopsy Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Breast Cancer Liquid Biopsy Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Breast Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Breast Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Breast Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Breast Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Breast Cancer Liquid Biopsy Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Breast Cancer Liquid Biopsy Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Breast Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Breast Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Breast Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Breast Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Breast Cancer Liquid Biopsy Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Breast Cancer Liquid Biopsy Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Breast Cancer Liquid Biopsy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Breast Cancer Liquid Biopsy Picture
Figure 2. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type in 2021
Figure 3. Circulating Tumor Cells (CTCs)
Figure 4. Cell-Free DNA (CfDNA)
Figure 5. Extracellular Vesicles (EVs)
Figure 6. Other Circulating Biomarkers
Figure 7. Breast Cancer Liquid Biopsy Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Laboratories Picture
Figure 11. Global Breast Cancer Liquid Biopsy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Breast Cancer Liquid Biopsy Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Breast Cancer Liquid Biopsy Revenue Market Share by Region (2017-2028)
Figure 14. Global Breast Cancer Liquid Biopsy Revenue Market Share by Region in 2021
Figure 15. North America Breast Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Breast Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Breast Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Breast Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Breast Cancer Liquid Biopsy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Breast Cancer Liquid Biopsy Market Drivers
Figure 21. Breast Cancer Liquid Biopsy Market Restraints
Figure 22. Breast Cancer Liquid Biopsy Market Trends
Figure 23. QIAGEN Recent Developments and Future Plans
Figure 24. Roche Diagnostics Recent Developments and Future Plans
Figure 25. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 26. Myriad Genetics Recent Developments and Future Plans
Figure 27. Menarini Silicon Biosystems Recent Developments and Future Plans
Figure 28. Genomic Health Recent Developments and Future Plans
Figure 29. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 30. Illumina Recent Developments and Future Plans
Figure 31. Biocept Recent Developments and Future Plans
Figure 32. Trovagene Recent Developments and Future Plans
Figure 33. Guardant Health Recent Developments and Future Plans
Figure 34. RainDance Technologies Recent Developments and Future Plans
Figure 35. MDx Health Recent Developments and Future Plans
Figure 36. Global Breast Cancer Liquid Biopsy Revenue Share by Players in 2021
Figure 37. Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Breast Cancer Liquid Biopsy Revenue Market Share in 2021
Figure 39. Global Top 10 Players Breast Cancer Liquid Biopsy Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Breast Cancer Liquid Biopsy Revenue Share by Type in 2021
Figure 42. Global Breast Cancer Liquid Biopsy Market Share Forecast by Type (2023-2028)
Figure 43. Global Breast Cancer Liquid Biopsy Revenue Share by Application in 2021
Figure 44. Global Breast Cancer Liquid Biopsy Market Share Forecast by Application (2023-2028)
Figure 45. North America Breast Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 46. North America Breast Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 47. North America Breast Cancer Liquid Biopsy Revenue Market Share by Country (2017-2028)
Figure 48. United States Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Breast Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 52. Europe Breast Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 53. Europe Breast Cancer Liquid Biopsy Revenue Market Share by Country (2017-2028)
Figure 54. Germany Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Breast Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Breast Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Breast Cancer Liquid Biopsy Revenue Market Share by Region (2017-2028)
Figure 62. China Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Breast Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 69. South America Breast Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 70. South America Breast Cancer Liquid Biopsy Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Breast Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Breast Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Breast Cancer Liquid Biopsy Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Breast Cancer Liquid Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
